Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Ishigaki

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Modern Rheumatology Case Reports|June 10, 2023
Successful treatment of refractory enteritis and arthritis with combination of tumour necrosis factor and interleukin-6 inhibition in patients with ulcerative colitisSho Ishigaki, Yasushi Kondo, Yuichiro Ota, et al.
Frontiers in Psychology|November 12, 2015
Are common names becoming less common? The rise in uniqueness and individualism in JapanYuji Ogihara, Hiroyo Fujita, Hitoshi Tominaga, et al.
Modern Rheumatology Case Reports|January 30, 2023
A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamideKoji Suzuki, Mitsuhiro Akiyama, Sho Ishigaki, et al.
Modern Rheumatology Case Reports|September 3, 2021
A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritisYuki Imai, Yasushi Kondo, Sho Ishigaki, et al.
Immunological Medicine|November 27, 2024
Expansion of granulocyte-macrophage colony-stimulating factor producing CD4+ T cells in an animal model with enhanced interleukin-1 signalSho Ishigaki, Keiko Yoshimoto, Mitsuhiro Akiyama, et al.
Clinical & Translational Immunology|July 12, 2021
Interleukin-1 pathway in active large vessel vasculitis patients with a poor prognosis: a longitudinal transcriptome analysisKotaro Matsumoto, Katsuya Suzuki, Keiko Yoshimoto, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 23, 2026
Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic SclerosisTomohisa Nakada, Ryuta Saito, Sho Ishigaki, et al.
Clinical and Experimental Rheumatology|October 22, 2024
Cytotoxic CX3CR1+ T cells drive vascular inflammation in giant cell arteritis but not in Takayasu's arteritisRisa Inukai, Mitsuhiro Akiyama, Keiko Yoshimoto, et al.
International Journal of Rheumatic Diseases|October 9, 2021
Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertensionHironari Hanaoka, Sho Ishigaki, Hiroshi Takei, et al.
Inflammation and Regeneration|February 5, 2025
CX3CR1<sup>+</sup> age-associated CD4<sup>+</sup> T cells contribute to synovial inflammation in late-onset rheumatoid arthritisMitsuhiro Akiyama, Sohma Wakasugi, Keiko Yoshimoto, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Modern Rheumatology Case Reports|June 10, 2023
Successful treatment of refractory enteritis and arthritis with combination of tumour necrosis factor and interleukin-6 inhibition in patients with ulcerative colitisSho Ishigaki, Yasushi Kondo, Yuichiro Ota, et al.
Frontiers in Psychology|November 12, 2015
Are common names becoming less common? The rise in uniqueness and individualism in JapanYuji Ogihara, Hiroyo Fujita, Hitoshi Tominaga, et al.
Modern Rheumatology Case Reports|January 30, 2023
A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamideKoji Suzuki, Mitsuhiro Akiyama, Sho Ishigaki, et al.
Modern Rheumatology Case Reports|September 3, 2021
A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritisYuki Imai, Yasushi Kondo, Sho Ishigaki, et al.
Immunological Medicine|November 27, 2024
Expansion of granulocyte-macrophage colony-stimulating factor producing CD4+ T cells in an animal model with enhanced interleukin-1 signalSho Ishigaki, Keiko Yoshimoto, Mitsuhiro Akiyama, et al.
Clinical & Translational Immunology|July 12, 2021
Interleukin-1 pathway in active large vessel vasculitis patients with a poor prognosis: a longitudinal transcriptome analysisKotaro Matsumoto, Katsuya Suzuki, Keiko Yoshimoto, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 23, 2026
Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic SclerosisTomohisa Nakada, Ryuta Saito, Sho Ishigaki, et al.
Clinical and Experimental Rheumatology|October 22, 2024
Cytotoxic CX3CR1+ T cells drive vascular inflammation in giant cell arteritis but not in Takayasu's arteritisRisa Inukai, Mitsuhiro Akiyama, Keiko Yoshimoto, et al.
International Journal of Rheumatic Diseases|October 9, 2021
Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertensionHironari Hanaoka, Sho Ishigaki, Hiroshi Takei, et al.
Inflammation and Regeneration|February 5, 2025
CX3CR1<sup>+</sup> age-associated CD4<sup>+</sup> T cells contribute to synovial inflammation in late-onset rheumatoid arthritisMitsuhiro Akiyama, Sohma Wakasugi, Keiko Yoshimoto, et al.
Pageof 3